Corleto KA
No ORCID on file
· 1 paper in corpus
· active 2025
Top journals
Frequent coauthors
- Cook KL 1
- Fabian CJ 1
- Giles ED 1
- Hursting SD 1
- Jenschke RM 1
- Kimler BF 1
- Komm BS 1
- Levin A 1
- Landrock D 1
- Mahmood TN 1
2025
Many risk-eligible women refuse tamoxifen for primary prevention of breast cancer due to concerns about common side effects such as vasomotor symptoms. Tamoxifen may also induce or worsen insulin resistance and hypertriglyceridemia, especia…